This event is fully booked, feel free to sign up for the waiting list.

at.las live event - “Clinical Development of ATMPs: narrowing the `conversion gap` between clinical trial and go-to market”.

QbD, Venn Life Sciences and at.las invite you to attend this event at the Science Park in Niel. 

The (pre)clinical development process is complex and risky. This is especially true for ATMP. Luckily, expert organisations are able to deliver strategic support as well as operational capabilities. Quality by Design and Venn Life Sciences will share their experiences. 


Will be discussed:

  • - ATMPs: what are the specificities
  • - The link between non-clinical and clinical development
  • - When discussing your non-clinical development with regulators?
  • - Non-clinical safety testing: what is important
  • - Identification of key decision points in development 
  • - ATMP challenges from development to pre-marketing authorization 

 

The Q&A will be moderated by prof. dr. Kris Thielemans, prof. em. VUB and co-founder eTheRNA Immunotherapies. 

 

Practical information:

  • - Date: Monday June 13th 2022 
  • - Time: 10.30 h – 13.00 h 
  • - Location: Science Park Niel, Galileilaan 15, 2845 Niel. 
  • - Participation is free of charge
  • - Lunch included 

 

Interested? Register now!